Laboratory Animal and Comparative Medicine ›› 2024, Vol. 44 ›› Issue (4): 393-404.DOI: 10.12300/j.issn.1674-5817.2024.013
• Animal Models of Human Diseases • Previous Articles Next Articles
DING Tiansong1, XIE Jinghong1()(
), YANG Bin1, LI Heqiao1, QIAO Yizhuo1, CHEN Xinru2, TIAN Wenfan2, LI Jiapei2, ZHANG Wanyi3, LI Fanxuan1
Received:
2024-01-22
Revised:
2024-06-05
Online:
2024-08-25
Published:
2024-09-06
Contact:
XIE Jinghong
CLC Number:
DING Tiansong,XIE Jinghong,YANG Bin,et al. Characteristics Evaluation and Application Analysis on Animal Models of Recurrent Spontaneous Abortion[J]. Laboratory Animal and Comparative Medicine, 2024, 44(4): 393-404. DOI: 10.12300/j.issn.1674-5817.2024.013.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.slarc.org.cn/dwyx/EN/10.12300/j.issn.1674-5817.2024.013
模型分类 Model classifications | 动物品种品系 animal strains | 文献频数(百分比/%) Frequency (Percentage /%) | 造模方法 Modeling methods |
---|---|---|---|
西医模型 Western medicine model | CBA/J小鼠(♀)×DBA/2小鼠(♂) | 120 (92.31) | 无需药物干预,成功妊娠即成模 |
BALB/c小鼠(♀)×BALB/c小鼠(♂) | 4 (3.08) | 子宫或腹腔注射β2-GP1 | |
Swiss白化小鼠(♀)×Swiss白化小鼠(♂) | 2 (1.54) | 腹腔注射LPS | |
SD大鼠(♀)×SD大鼠(♂) | 1 (0.77) | 皮下注射溴隐亭 | |
C57BL/6小鼠(♀)×C57BL/6小鼠(♂) | 1 (0.77) | 腹腔注射LPS | |
CBA/J小鼠(♀)×CBA/J小鼠(♂) | 1 (0.77) | 尾静脉注射JL-1 | |
SD大鼠(♀)×SD大鼠(♂) | 1 (0.77) | 皮下注射aCL-IgG | |
中医病证结合模型 TCM disease and syndrome combination model | SD大鼠(♀)×SD大鼠(♂) | 7 (70.00) | 羟基脲灌胃+米非司酮灌胃(肾虚-黄体抑制) |
CBA/J小鼠(♀)×BALB/c小鼠(♂) | 2 (20.00) | 羟基脲灌胃+肾上腺素皮下注射(肾虚血瘀) | |
CBA/J小鼠(♀)×DBA/2小鼠(♂) | 1 (10.00) | 附子、干姜、肉桂溶液灌胃(虚热) |
Table 1 Establishment methods of animal models for recurrent spontaneous abortion
模型分类 Model classifications | 动物品种品系 animal strains | 文献频数(百分比/%) Frequency (Percentage /%) | 造模方法 Modeling methods |
---|---|---|---|
西医模型 Western medicine model | CBA/J小鼠(♀)×DBA/2小鼠(♂) | 120 (92.31) | 无需药物干预,成功妊娠即成模 |
BALB/c小鼠(♀)×BALB/c小鼠(♂) | 4 (3.08) | 子宫或腹腔注射β2-GP1 | |
Swiss白化小鼠(♀)×Swiss白化小鼠(♂) | 2 (1.54) | 腹腔注射LPS | |
SD大鼠(♀)×SD大鼠(♂) | 1 (0.77) | 皮下注射溴隐亭 | |
C57BL/6小鼠(♀)×C57BL/6小鼠(♂) | 1 (0.77) | 腹腔注射LPS | |
CBA/J小鼠(♀)×CBA/J小鼠(♂) | 1 (0.77) | 尾静脉注射JL-1 | |
SD大鼠(♀)×SD大鼠(♂) | 1 (0.77) | 皮下注射aCL-IgG | |
中医病证结合模型 TCM disease and syndrome combination model | SD大鼠(♀)×SD大鼠(♂) | 7 (70.00) | 羟基脲灌胃+米非司酮灌胃(肾虚-黄体抑制) |
CBA/J小鼠(♀)×BALB/c小鼠(♂) | 2 (20.00) | 羟基脲灌胃+肾上腺素皮下注射(肾虚血瘀) | |
CBA/J小鼠(♀)×DBA/2小鼠(♂) | 1 (10.00) | 附子、干姜、肉桂溶液灌胃(虚热) |
年龄 Age | 文献频数/次(小鼠/大鼠) Frequency/times (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|
6~8周龄 6~8 weeks old | 43 (40/3) | 33.86 (31.50/2.26) |
8周龄 8 weeks old | 41 (40/1) | 32.28 (31.50/0.79) |
8~10周龄 8~10 weeks old | 28 (27/1) | 22.05 (21.26/0.79) |
≥10周龄 ≥10 weeks old | 8 (7/1) | 6.30 (5.51/0.79) |
10~12周龄 10~12 weeks old | 3 (2/1) | 2.26 (1.57/0.79) |
8~12周龄 8~12 weeks old | 3 (3/0) | 2.26 (2.26/0) |
9~11周龄 9~11 weeks old | 1 (1/0) | 0.79 (0.79/0) |
Table 2 Age distribution of experimental animals used in recurrent spontaneous abortion models
年龄 Age | 文献频数/次(小鼠/大鼠) Frequency/times (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|
6~8周龄 6~8 weeks old | 43 (40/3) | 33.86 (31.50/2.26) |
8周龄 8 weeks old | 41 (40/1) | 32.28 (31.50/0.79) |
8~10周龄 8~10 weeks old | 28 (27/1) | 22.05 (21.26/0.79) |
≥10周龄 ≥10 weeks old | 8 (7/1) | 6.30 (5.51/0.79) |
10~12周龄 10~12 weeks old | 3 (2/1) | 2.26 (1.57/0.79) |
8~12周龄 8~12 weeks old | 3 (3/0) | 2.26 (2.26/0) |
9~11周龄 9~11 weeks old | 1 (1/0) | 0.79 (0.79/0) |
造模过程评定项目 Molding process assessment item | 时间或次数 Time or frequency | 文献频数(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|---|
合笼交配时间 Cage mating | 交配日18:00 | 6 (6/0) | 60.00 (60.00/0) |
交配日20:00 | 2 (2/0) | 20.00 (20.00/0) | |
交配日17:00 | 1 (1/0) | 10.00 (10.00/0) | |
交配日晚上 | 1 (1/0) | 20.00 (20.00/0) | |
阴栓检查频次 Frequency vaginal plug examination | 合笼后每日1次 | 47 (42/5) | 81.03 (72.41/8.62) |
合笼后每日2次 | 11 (8/3) | 18.97 (13.79/5.17) | |
阴栓检查时间 Vaginal plug examination time | 次日清晨 | 13 (11/2) | 27.66 (23.40/4.26) |
次晨 | 8 (8/0) | 17.02 (17.02/0) | |
次日8:00 | 8 (8/0) | 17.02 (17.02/0) | |
次日早晨 | 7 (5/2) | 14.89 (10.64/4.26) | |
仅提及每日1次 | 2 (2/0) | 4.26 (4.26/0) | |
次日5:00-6:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日6:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日6:00-7:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日7:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日8:30 | 1 (1/0) | 2.13 (2.13/0) | |
次日10:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日9:00-11:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日早晨 | 1 (1/0) | 2.13 (2.13/0) | |
次日上午 | 1 (0/1) | 2.13 (2.13/0) | |
次日8:00和14:00 | 5 (1/0) | 45.45 (45.45/0) | |
次日8:00和15:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚7:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚8:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚9:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早、晚 | 1 (1/0) | 9.09 (9.09/0) | |
仅提及每日2次 | 1 (1/0) | 9.09 (9.09/0) |
Table 3 Evaluation of the modeling process of recurrent spontaneous abortion animal models
造模过程评定项目 Molding process assessment item | 时间或次数 Time or frequency | 文献频数(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|---|
合笼交配时间 Cage mating | 交配日18:00 | 6 (6/0) | 60.00 (60.00/0) |
交配日20:00 | 2 (2/0) | 20.00 (20.00/0) | |
交配日17:00 | 1 (1/0) | 10.00 (10.00/0) | |
交配日晚上 | 1 (1/0) | 20.00 (20.00/0) | |
阴栓检查频次 Frequency vaginal plug examination | 合笼后每日1次 | 47 (42/5) | 81.03 (72.41/8.62) |
合笼后每日2次 | 11 (8/3) | 18.97 (13.79/5.17) | |
阴栓检查时间 Vaginal plug examination time | 次日清晨 | 13 (11/2) | 27.66 (23.40/4.26) |
次晨 | 8 (8/0) | 17.02 (17.02/0) | |
次日8:00 | 8 (8/0) | 17.02 (17.02/0) | |
次日早晨 | 7 (5/2) | 14.89 (10.64/4.26) | |
仅提及每日1次 | 2 (2/0) | 4.26 (4.26/0) | |
次日5:00-6:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日6:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日6:00-7:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日7:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日8:30 | 1 (1/0) | 2.13 (2.13/0) | |
次日10:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日9:00-11:00 | 1 (1/0) | 2.13 (2.13/0) | |
次日早晨 | 1 (1/0) | 2.13 (2.13/0) | |
次日上午 | 1 (0/1) | 2.13 (2.13/0) | |
次日8:00和14:00 | 5 (1/0) | 45.45 (45.45/0) | |
次日8:00和15:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚7:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚8:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早晚9:00 | 1 (1/0) | 9.09 (9.09/0) | |
次日早、晚 | 1 (1/0) | 9.09 (9.09/0) | |
仅提及每日2次 | 1 (1/0) | 9.09 (9.09/0) |
序号 No. | 检测方法(指标) Type of detection method (detection index) | 频数(百分比/%) Frequency (Percentage/%) |
---|---|---|
1 | 胚胎肉眼观察(胚胎吸收率、流产率等) | 96 (22.54) |
2 | 蛋白质印迹(TGF-β1、PI3K、PKB等) | 68 (15.96) |
3 | PCR(HK2、PKM2、LDHA mRNA等) | 59 (13.85) |
4 | ELISA(IFN-γ、IL-10、IL-1β、TNF-α等) | 55 (12.91) |
5 | HE染色(母胎界面滋养细胞形态等) | 46 (10.80) |
6 | 免疫组织化学(TGF-β1、PI3K、PKB) | 40 (9.39) |
7 | 流式细胞术(CD4+、CD25+、Treg 细胞计数等) | 31 (7.28) |
8 | 免疫荧光(iNOS、IL-6、TNF-α、Arg-1等) | 11 (2.58) |
9 | 脏器指数(脾脏、胸腺、子宫等) | 3 (0.70) |
10 | 双荧光素酶实验(miR-187和VEGF靶向关系等);质谱检测(蜕膜蛋白质组);生殖力指标(每窝产仔数,鼠仔出生体重等);磷酸化检测(STAT1、STAT3、STAT6) | 2 (0.47) |
11 | 硝酸还原酶法检测(NO);TUNEL荧光检测(蜕膜组织细胞凋亡);双向电泳(蜕膜蛋白质组);乳酸脱氢酶比色法(HK、PK、LDH酶活性检测);Label-free蛋白质组学(胎盘组织);免疫金-电镜分析(TTP);功能活性测定;血细胞计数(PLT);凝血检查(APTT、PT、FIB) | 1 (0.23) |
Table 4 Phenotypic evaluation indicators and detection methods of recurrent spontaneous abortion animal models
序号 No. | 检测方法(指标) Type of detection method (detection index) | 频数(百分比/%) Frequency (Percentage/%) |
---|---|---|
1 | 胚胎肉眼观察(胚胎吸收率、流产率等) | 96 (22.54) |
2 | 蛋白质印迹(TGF-β1、PI3K、PKB等) | 68 (15.96) |
3 | PCR(HK2、PKM2、LDHA mRNA等) | 59 (13.85) |
4 | ELISA(IFN-γ、IL-10、IL-1β、TNF-α等) | 55 (12.91) |
5 | HE染色(母胎界面滋养细胞形态等) | 46 (10.80) |
6 | 免疫组织化学(TGF-β1、PI3K、PKB) | 40 (9.39) |
7 | 流式细胞术(CD4+、CD25+、Treg 细胞计数等) | 31 (7.28) |
8 | 免疫荧光(iNOS、IL-6、TNF-α、Arg-1等) | 11 (2.58) |
9 | 脏器指数(脾脏、胸腺、子宫等) | 3 (0.70) |
10 | 双荧光素酶实验(miR-187和VEGF靶向关系等);质谱检测(蜕膜蛋白质组);生殖力指标(每窝产仔数,鼠仔出生体重等);磷酸化检测(STAT1、STAT3、STAT6) | 2 (0.47) |
11 | 硝酸还原酶法检测(NO);TUNEL荧光检测(蜕膜组织细胞凋亡);双向电泳(蜕膜蛋白质组);乳酸脱氢酶比色法(HK、PK、LDH酶活性检测);Label-free蛋白质组学(胎盘组织);免疫金-电镜分析(TTP);功能活性测定;血细胞计数(PLT);凝血检查(APTT、PT、FIB) | 1 (0.23) |
受试药种类 Tested drugs | 频数/次(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|
受试西药Western drugs tested | ||
蛋白(环孢素A、IVIG等) | 7 (7/0) | 29.17 (29.17/0) |
细胞(Treg、间充质干细胞等) | 6 (6/0) | 25.00 (25.00/0) |
西药(二甲双胍、普伐他汀等) | 4 (2/2) | 16.67 (8.33/8.33) |
转染miRNA(miR-24、146、203) | 3 (3/0) | 12.50 (12.50/0) |
因子(IL-7、CXCL12/CCL2/RANTES) | 2 (2/0) | 8.33 (8.33/0) |
化工试剂(二氧化硅颗粒) | 1 (1/0) | 4.17 (4.17/0) |
西药化合物(SR9009) | 1 (1/0) | 4.17 (4.17/0) |
受试中药 Chinese medicine tested | ||
中药汤剂(寿胎丸、泰山磐石散等) | 73 (67/6) | 81.11 (74.44/6.67) |
中药化合物(黄芩苷、丹参酮ⅡA等) | 12 (10/2) | 13.33 (11.11/2.22) |
中药水煎液(味数≤2)(黄芩、白术等) | 4 (4/0) | 4.44 (4.44/0) |
中成药(孕康口服液) | 1 (1/0) | 1.11 (1.11/0) |
Table 5 Types of drugs tested in recurrent spontaneous abortion animal models
受试药种类 Tested drugs | 频数/次(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|
受试西药Western drugs tested | ||
蛋白(环孢素A、IVIG等) | 7 (7/0) | 29.17 (29.17/0) |
细胞(Treg、间充质干细胞等) | 6 (6/0) | 25.00 (25.00/0) |
西药(二甲双胍、普伐他汀等) | 4 (2/2) | 16.67 (8.33/8.33) |
转染miRNA(miR-24、146、203) | 3 (3/0) | 12.50 (12.50/0) |
因子(IL-7、CXCL12/CCL2/RANTES) | 2 (2/0) | 8.33 (8.33/0) |
化工试剂(二氧化硅颗粒) | 1 (1/0) | 4.17 (4.17/0) |
西药化合物(SR9009) | 1 (1/0) | 4.17 (4.17/0) |
受试中药 Chinese medicine tested | ||
中药汤剂(寿胎丸、泰山磐石散等) | 73 (67/6) | 81.11 (74.44/6.67) |
中药化合物(黄芩苷、丹参酮ⅡA等) | 12 (10/2) | 13.33 (11.11/2.22) |
中药水煎液(味数≤2)(黄芩、白术等) | 4 (4/0) | 4.44 (4.44/0) |
中成药(孕康口服液) | 1 (1/0) | 1.11 (1.11/0) |
给药方式 Mode of administration | 给药时间 Time of administration | 频数(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|---|
单次给药Single-dose | 妊娠后第4天 | 2 (2/0) | 28.57 (28.57/0) |
妊娠后第1天 | 1 (1/0) | 14.29 (14.29/0) | |
合笼前第21天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠第4.5天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠后第7.5天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠后第15.5天 | 1 (1/0) | 14.29 (14.29/0) | |
连续多次给药 Continuous multiple dose | 妊娠后连续14 d | 43 (41/2) | 42.57 (40.59/1.98) |
妊娠后连续15 d | 12 (11/1) | 11.88 (10.89/0.99) | |
合笼前至妊娠后持续给药 | 11 (11/0) | 10.89 (10.89/0) | |
妊娠后连续12 d | 7 (7/0) | 6.93 (6.93/0) | |
妊娠后连续9 d | 4 (4/0) | 3.96 (3.96/0) | |
妊娠后连续16 d | 4 (4/0) | 3.96 (3.96/0) | |
合笼前给药 | 4 (4/0) | 3.96 (3.96/0) | |
妊娠后连续8 d | 3 (3/0) | 2.97 (2.97/0) | |
妊娠后连续7 d | 2 (2/0) | 1.98 (1.98/0) | |
妊娠后连续5 d | 2 (2/0) | 1.98 (1.98/0) | |
妊娠后连续10 d | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后连续11 d | 1 (0/1) | 0.99 (0.99/0) | |
妊娠后第4~6天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第4~8天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第4~9天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第5~14天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第7~15天 | 1 (0/1) | 0.99 (0.99/0) | |
交配前及妊娠第6~9天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第2~6周 | 1 (1/0) | 0.99 (0.99/0) | |
间隔给药 Intermittent administration | 合笼前腹腔注射给药,biw,共4周 | 1 (1/0) | 16.67 (16.67/0) |
妊娠后尾静脉注射,q2d,共3次 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第0天腹腔注射,q3d,共5次 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第8天和第12天尾静脉注射 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第4.5、6.5、8.5天腹腔注射 | 1 (1/0) | 16.67 (16.67/0) | |
合笼时尾静脉注射1次,q3d,共5次 | 1 (1/0) | 16.67 (16.67/0) |
Table 6 Mode of administration of tested drugs in pharmacological and pharmacodynamic studies using recurrent spontaneous abortion animal models
给药方式 Mode of administration | 给药时间 Time of administration | 频数(小鼠/大鼠) Frequency (mouse/rat) | 百分比/%(小鼠/大鼠) Percentage /% (mouse/rat) |
---|---|---|---|
单次给药Single-dose | 妊娠后第4天 | 2 (2/0) | 28.57 (28.57/0) |
妊娠后第1天 | 1 (1/0) | 14.29 (14.29/0) | |
合笼前第21天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠第4.5天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠后第7.5天 | 1 (1/0) | 14.29 (14.29/0) | |
妊娠后第15.5天 | 1 (1/0) | 14.29 (14.29/0) | |
连续多次给药 Continuous multiple dose | 妊娠后连续14 d | 43 (41/2) | 42.57 (40.59/1.98) |
妊娠后连续15 d | 12 (11/1) | 11.88 (10.89/0.99) | |
合笼前至妊娠后持续给药 | 11 (11/0) | 10.89 (10.89/0) | |
妊娠后连续12 d | 7 (7/0) | 6.93 (6.93/0) | |
妊娠后连续9 d | 4 (4/0) | 3.96 (3.96/0) | |
妊娠后连续16 d | 4 (4/0) | 3.96 (3.96/0) | |
合笼前给药 | 4 (4/0) | 3.96 (3.96/0) | |
妊娠后连续8 d | 3 (3/0) | 2.97 (2.97/0) | |
妊娠后连续7 d | 2 (2/0) | 1.98 (1.98/0) | |
妊娠后连续5 d | 2 (2/0) | 1.98 (1.98/0) | |
妊娠后连续10 d | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后连续11 d | 1 (0/1) | 0.99 (0.99/0) | |
妊娠后第4~6天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第4~8天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第4~9天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第5~14天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第7~15天 | 1 (0/1) | 0.99 (0.99/0) | |
交配前及妊娠第6~9天 | 1 (1/0) | 0.99 (0.99/0) | |
妊娠后第2~6周 | 1 (1/0) | 0.99 (0.99/0) | |
间隔给药 Intermittent administration | 合笼前腹腔注射给药,biw,共4周 | 1 (1/0) | 16.67 (16.67/0) |
妊娠后尾静脉注射,q2d,共3次 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第0天腹腔注射,q3d,共5次 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第8天和第12天尾静脉注射 | 1 (1/0) | 16.67 (16.67/0) | |
妊娠第4.5、6.5、8.5天腹腔注射 | 1 (1/0) | 16.67 (16.67/0) | |
合笼时尾静脉注射1次,q3d,共5次 | 1 (1/0) | 16.67 (16.67/0) |
1 | HACHEM H E, CREPAUX V, MAY-PANLOUP P, et al. Recurrent pregnancy loss: current perspectives[J]. Int J Womens Health, 2017, 9:331-345. DOI: 10.2147/IJWH.S100817 . |
2 | 常卓, 朱慧, 周雪明, 等. 补肾活血方对不明原因复发性流产小鼠蜕膜化过程中p53、p21的影响[J]. 中华中医药杂志, 2022, 37(1):473-477. |
CHANG Z, ZHU H, ZHOU X M, et al. Effects of Bushen Huoxue Decoction on p53 and p21 in decidualization of mice with unexplained recurrent abortion[J]. China J Tradit Chin Med Pharm, 2022, 37(1):473-477. | |
3 | 吴立群, 杨培丹, 易玮. 复发性流产中西医病因病机及针灸治疗思路[J]. 辽宁中医药大学学报, 2020, 22(1):208-212. DOI: 10.13194/j.issn.1673-842x.2020.01.056 . |
WU L Q, YANG P D, YI W. Etiology and pathogenesis of recurrent abortion in Chinese and western medicine and treatment ideas of acupuncture[J]. J Liaoning Univ Tradit Chin Med, 2020, 22(1):208-212. DOI: 10.13194/j.issn.1673-842x.2020.01.056 . | |
4 | 陈莎, 谢京红, 周文清, 等. 补肾助孕法孕前调理治疗复发性流产的临床观察[J]. 中国中医基础医学杂志, 2019, 25(10):1397-1400. DOI: 10.19945/j.cnki.issn.1006-3250.2019.10.025 . |
CHEN S, XIE J H, ZHOU W Q, et al. Clinical observation on the treatment of recurrent spontaneous abortion by tonifying kidney and promoting pregnancy before pregnancy[J]. Chin J Basic Med Tradit Chin Med, 2019, 25(10):1397-1400. DOI: 10.19945/j.cnki.issn.1006-3250.2019.10.025 . | |
5 | 李洁. 2016年中国"复发性流产诊治的专家共识"与2017年欧洲"复发性流产诊治指南" 的解读[J]. 实用妇产科杂志, 2018, 34(11):822-825. DOI:CNKI:SUN:SFCZ.0.2018-11-011 . |
LI J. Interpretation of "expert consensus on diagnosis and treatment of recurrent abortion" in China in 2016 and "guidelines on diagnosis and treatment of recurrent abortion" in Europe in 2017[J]. J Pract Obstet Gynecol, 2018, 34(11):822-825. DOI:CNKI:SUN:SFCZ.0.2018-11-011 . | |
6 | CLARK D A, MCDERMOTT M R, SZEWCZUK M R. Impairment of host-versus-graft reaction in pregnant mice: II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy[J]. Cell Immunol, 1980, 52(1):106-118. DOI:10.1016/ 0008-8749(80)90404-9 . |
7 | 张钰, 王建梅, 顾艳, 等. 调节趋化因子CXCL12、CCL2、RANTES及其受体表达对自然流产模型小鼠妊娠结局的影响[J]. 中国妇幼保健, 2015, 30(15):2407-2411. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.15.42 . |
ZHANG Y, WANG J M, GU Y, et al. Effects of regulation of expressions of chemokines-CXCL12, CCL2, RANTES and their receptors on pregnancy outcome of mouse model of spontaneous abortion[J]. Matern Child Health Care China, 2015, 30(15):2407-2411. DOI: 10.7620/zgfybj.j.issn.1001-4411.2015.15.42 . | |
8 | RODRIGUES V O, SOLIGO A G E S, PANNAIN G D. Antiphospholipid antibody syndrome and infertility[J]. Rev Bras Ginecol Obstet, 2019, 41(10):621-627. DOI: 10.1055/s-0039-1697982 . |
9 | RADU A, DUDU S C, CIOBANU A, et al. Pregnancy management in women with antiphospholidic syndrome[J]. Maedica, 2019, 14(2):148-160. DOI: 10.26574/maedica.2019.14.2.148 . |
10 | 丁超, 陆启滨. β2-糖蛋白Ⅰ与抗心磷脂抗体阳性先兆流产的关系以及安子合剂干预作用的实验研究[J]. 南京中医药大学学报, 2014, 30(4):344-346. DOI: 10.14148/j.issn.1672-0482.2014.04.013 . |
DING C, LU Q B. Research on relationship between β2-GPⅠand ACA-positive threatened abortion and intervention effects of anzi mixture[J]. J Nanjing Univ Tradit Chin Med, 2014, 30(4):344-346. DOI: 10.14148/j.issn.1672-0482.2014.04.013 . | |
11 | 谢雅贞, 陆启滨. 抗心磷脂抗体阳性复发性流产小鼠胎盘的差异蛋白组学研究[J]. 生殖医学杂志, 2021, 30(2):209-216. DOI: 10.3969/j.issn.1004-3845.2021.02.014 . |
XIE Y Z, LU Q B. Differential proteomics study on placenta of mice with anticardiolipin antibody positive recurrent abortion[J]. J Reprod Med, 2021, 30(2):209-216. DOI: 10.3969/j.issn.1004-3845.2021.02.014 . | |
12 | OHMURA K, OKU K, KITAORI T, et al. Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss[J]. Clin Immunol, 2019, 203:37-44. DOI: 10.1016/j.clim.2019.04.005 . |
13 | 岳超, 李捷. 抗心磷脂抗体、抗β2糖蛋白Ⅰ抗体、抗dsDNA抗体、抗C1q抗体在复发性流产诊断中的价值分析[J]. 中国实验诊断学, 2021, 25(11):1631-1635. DOI: 10.3969/j.issn.1007-4287.2021.11.013 . |
YUE C, LI J. Value analysis of anticardiolipin antibody, antiβ2 glycoprotein I antibody, anti dsDNA antibody and anti C1q antibody in the diagnosis of recurrent miscarriage[J]. Chin J Lab Diagn, 2021, 25(11):1631-1635. DOI: 10.3969/j.issn.1007-4287.2021.11.013 . | |
14 | 马爱团, 钟秀会, 孟立根, 等. 溴隐亭对小鼠生育的影响及其作用机理[J]. 动物学报, 2006, 52(3):536-541. |
MA A T, ZHONG X H, MENG L G, et al. Effect of Bromocriptine and its mechanism on the fertility in the mouse[J]. Acta Zool Sin, 2006, 52(3):536-541. | |
15 | 周子清. 革兰氏阴性细菌脂多糖的流产作用[J]. 生殖与避孕, 1981, 1(2):13-15. |
ZHOU Z Q. Abortion effect of lipopolysaccharide from gram-negative bacteria[J]. Reprod Contracept, 1981, 1(2):13-15. | |
16 | CUI L Y, XU F, WANG S C, et al. Pharmacological activation of rev-erbα suppresses LPS-induced macrophage M1 polarization and prevents pregnancy loss[J]. BMC Immunol, 2021, 22(1):57. DOI: 10.1186/s12865-021-00438-4 . |
17 | 吴玉泓, 魏彦明, 郭延生. 大鼠实验性流产模型的建立及黄芪多糖对其的影响[J]. 中国实验动物学报, 2010, 18(4):341-344. DOI: 10.3969/j.issn.1005-4847.2010.04.016 . |
WU Y H, WEI Y M, GUO Y S. Establishment of a LPS-induced rat model of abortion and the effect of Astragalus polysacharin on it[J]. Acta Lab Anim Sci Sin, 2010, 18(4):341-344. DOI: 10.3969/j.issn.1005-4847.2010.04.016 . | |
18 | 施秋秋, 颜美秋, 余欢欢, 等. 孕康口服液对LPS诱导小鼠流产的保胎及免疫耐受调节作用研究[J]. 中国中药杂志, 2019, 44(6):1227-1232. DOI: 10.19540/j.cnki.cjcmm.20181218.002 . |
SHI Q Q, YAN M Q, YU H H, et al. Effect of Yunkang Oral Liquid on preventing LPS-induced abortion and regulating immune tolerance in mice[J]. China J Chin Mater Med, 2019, 44(6):1227-1232. DOI: 10.19540/j.cnki.cjcmm.20181218.002 . | |
19 | SABAN N, BUJAK M. Hydroxyurea and hydroxamic acid derivatives as antitumor drugs[J]. Cancer Chemother Pharmacol, 2009, 64(2):213-221. DOI: 10.1007/s00280-009-0991-z . |
20 | 马小娟, 马文礼, 王丽新. 不同造模周期对羟基脲致肾阳虚动物模型的影响[J]. 中国实验动物学报, 2023, 31(1):64-74. DOI: 10.3969/j.issn.1005-4847.2023.01.008 . |
MA X J, MA W L, WANG L X. Effect of different modeling periods on hydroxyurea-induced kidney-yang deficiency animal model[J]. Acta Lab Anim Sci Sin, 2023, 31(1):64-74. DOI: 10.3969/j.issn.1005-4847.2023.01.008 . | |
21 | 魏静, 刘海青, 刘冬梅. 米非司酮联合米索前列醇用于不同孕周药物流产效果[J]. 中国计划生育学杂志, 2024, 32(3):533-536. |
WEI J, LIU H Q, LIU D M. Effect of mifepristone combined with misoprostol for abortion of women with different gestational weeks[J]. Chin J Fam Plan, 2024, 32(3):533-536. | |
22 | 王祈帆, 买占海, 张晓松, 等. 3种流产剂对大鼠妊娠干预作用的比较研究[J]. 动物医学进展, 2024, 45(2):64-69. DOI: 10.16437/j.cnki.1007-5038.2024.02.006 . |
WANG Q F, MAI Z H, ZHANG X S, et al. A comparative study of the effects of three abortifacient on pregnancy intervention in rats[J]. Prog Vet Med, 2024, 45(2):64-69. DOI: 10.16437/j.cnki.1007-5038.2024.02.006 . | |
23 | 谢宝珍, 郜洁, 曾丽华, 等. 中医妇科病证结合流产动物模型的研究思路[J]. 中华中医药杂志, 2022, 37(2):589-594. |
XIE B Z, GAO J, ZENG L H, et al. Research ideas of animal models combining spontaneous abortion with traditional Chinese medicine syndrome[J]. China J Tradit Chin Med Pharm, 2022, 37(2):589-594. | |
24 | 张铭. 助孕3号方对脾虚黄体抑制动物流产模型的作用[J]. 广州中医药大学学报, 2000, 17(1):64-68. DOI: 10.3969/j.issn.1007-3213.2000.01.017 . |
ZHANG M. Effect of Zhuyun Ⅲ on animal models with abortion induced by inhibition of corpus luteum[J]. J Guangzhou Univ Tradit Chin Med, 2000, 17(1):64-68. DOI: 10.3969/j.issn.1007-3213.2000.01.017 . | |
25 | 宋程程, 王志斌, 苏斌, 等. 常用大鼠血瘀证模型的比较研究[J]. 北京中医药大学学报, 2014, 37(2):94-98. DOI: 10.3969/j.issn.1006-2157.2014.02.006 . |
SONG C C, WANG Z B, SU B, et al. Study on commonly used rat model of blood stasis syndrome[J]. J Beijing Univ Tradit Chin Med, 2014, 37(2):94-98. DOI: 10.3969/j.issn.1006-2157.2014.02.006 . | |
26 | 宋晓丹, 成秀梅, 周湘, 等. 寒凝血瘀证动物模型研究现状[J]. 中国实验方剂学杂志, 2022, 28(15):267-274. DOI: 10.13422/j.cnki.syfjx.20221593 . |
SONG X D, CHENG X M, ZHOU X, et al. Animal model of cold congeal and blood stasis syndrome: a review[J]. Chin J Exp Tradit Med Formulae, 2022, 28(15):267-274. DOI: 10.13422/j.cnki.syfjx.20221593 . | |
27 | 马丽亚, 赵君玫, 王磊, 等. CBA/J小鼠虚热型反复自然流产模型的建立[J]. 中医学报, 2020, 35(2):358-361. DOI: 10.16368/j.issn.1674-8999.2020.02.081 . |
MA L Y, ZHAO J M, WANG L, et al. Establishment of recurrent spontaneous abortion with deficiency heat syndrome in CBA/J model mice[J]. Acta Chin Med, 2020, 35(2):358-361. DOI: 10.16368/j.issn.1674-8999.2020.02.081 . | |
28 | 闫晗, 何桂林, 张晓芳, 等. 如何提高实验动物的交配成功率[J]. 毒理学杂志, 2007, 21(4):318. DOI: 10.16421/j.cnki.1002-3127.2007.04.058 . |
YAN H, HE G L, ZHANG X F, et al. How to improve the mating success rate of experimental animals[J]. J Toxicol, 2007, 21(4):318. DOI: 10.16421/j.cnki.1002-3127.2007.04.058 . | |
29 | 易楚, 詹莎, 马昕怡, 等. 卵巢癌动物模型的特点及应用分析[J]. 中国实验动物学报, 2023, 31(10):1324-1333. DOI: 10.3969/j.issn.1005-4847.2023.10.010 . |
YI C, ZHAN S, MA X Y, et al. Characteristics and application analysis of animal models of ovarian cancer[J]. Acta Lab Anim Sci Sin, 2023, 31(10):1324-1333. DOI: 10.3969/j.issn.1005-4847.2023.10.010 . | |
30 | 娄艺楠, 李秀敏, 樊帅珂, 等. 基于中西医临床病证特点的慢性支气管炎动物模型分析[J]. 中药药理与临床, 2021, 7(4):200-204. |
LOU Y N, LI X M, FAN S K, et al. Analysis of chronic bronchitis animal model based on the characteristics of clinical symptoms in Chinese and western medicine[J]. Pharmacol Clin Chin Mater Med, 2021, 7(4):200-204. | |
31 | 陈滢如, 朱江, 苑鸿雯, 等. 性周期筛选合笼与非筛选合笼制备大鼠妊娠模型的比较[J]. 中国比较医学杂志, 2010, 20(9):41-43, 84. DOI: 10.3969/j.issn.1671-7856.2010.09.012 . |
CHEN Y R, ZHU J, YUAN H W, et al. Comparative research of preparing rat pregnancy model via mating after screening sexual cycle by vaginal smear or free mating without screening[J]. Chin J Comp Med, 2010, 20(9):41-43, 84. DOI: 10.3969/j.issn.1671-7856.2010.09.012 . | |
32 | 李河桥, 谢京红, 杨斌, 等. 蔡连香运用"精血"理论辨治复发性流产经验探析[J]. 江苏中医药, 2023, 55(10):21-24. DOI: 10.19844/j.cnki.1672-397X.2023.10.007 . |
LI H Q, XIE J H, YANG B, et al. CAI Lianxiang's experience in treating recurrent abortion by the theory of "essence and blood"[J]. Jiangsu J Tradit Chin Med, 2023, 55(10):21-24. DOI: 10.19844/j.cnki.1672-397X.2023.10.007 . | |
33 | 梁潇, 唐思玲, 宋亚静, 等. 寿胎丸对复发性流产模型小鼠胚胎有氧糖酵解关键酶及相关蛋白表达的影响[J]. 中医杂志, 2023, 64(10):1044-1050. DOI: 10.13288/j.11-2166/r.2023.10.013 . |
LIANG X, TANG S L, SONG Y J, et al. Effects of Shoutai pills on the expression of key enzymes and related proteins of aerobic glycolysis in embryos of recurrent spontaneous abortion model mice[J]. J Tradit Chin Med, 2023, 64(10):1044-1050. DOI: 10.13288/j.11-2166/r.2023.10.013 . | |
34 | 唐思玲, 梁潇, 李荣霞, 等. 寿胎丸对复发性流产小鼠胚胎滋养细胞上皮间质转化的影响[J]. 北京中医药大学学报, 2023, 46(8):1139-1149. DOI: 10.3969/j.issn.1006-2157.2023.08.012 . |
TANG S L, LIANG X, LI R X, et al. Effects of Shoutai Pills on EMT of embryonic trophoblasts in recurrent spontaneous abortion mice[J]. J Beijing Univ Tradit Chin Med, 2023, 46(8):1139-1149. DOI: 10.3969/j.issn.1006-2157.2023.08.012 . | |
35 | 许春月, 郭洁, 宋殿荣, 等. 寿胎丸对复发性流产小鼠蜕膜组织中螺旋动脉改变及怀孕结局的影响[J]. 国际妇产科学杂志, 2017, 44(4):443-447, 封2. DOI: 10.3969/j.issn.1674-1870.2017.04.018 . |
XU C Y, GUO J, SONG D R, et al. Study on spiral artery transformation and pregnancy outcome of recurrent spontaneous abortion mice treated with shoutaiwan[J]. J Int Obstet Gynecol, 2017, 44(4):443-447, inside front cover. DOI: 10.3969/j.issn.1674-1870.2017.04.018 . | |
36 | 石琳. IL-7对不明原因复发性流产小鼠模型外周Th17/Treg、CD4+ CD8+T淋巴细胞以及妊娠结局的影响[J]. 中国妇幼保健, 2016, 31(2):390-392. DOI: 10.7620/zgfybj.j.issn.1001-4411.2016.02.60 . |
SHI L. Effects of IL-7 on peripheral Th17/Treg, CD4+ CD8+T lymphocytes and pregnancy outcome in mice with unexplained recurrent abortion[J]. Matern Child Health Care China, 2016, 31(2):390-392. DOI: 10.7620/zgfybj.j.issn.1001-4411.2016.02.60 . | |
37 | 于玲玉, 王振国. 重析"黄芩白术乃安胎圣药"[J]. 中华中医药杂志, 2023, 38(9):4052-4055. |
YU L Y, WANG Z G. Re-analysis of the saying of 'Scutellariae Radix and Atractylodis Macrocephalae Rhizoma are the holy medicines for calming the fetus'[J]. China J Tradit Chin Med Pharm, 2023, 38(9):4052-4055. | |
38 | 牟珍妮, 申思楠, 唐丽, 等. 基于JAK1/STAT3通路的寿胎丸对复发性流产小鼠细胞自噬的影响[J]. 中国中医药信息杂志, 2023, 30(6):87-93. DOI: 10.19879/j.cnki.1005-5304.202207237 . |
MU Z N, SHEN S N, TANG L, et al. Effects of Shoutai pills on autophagy in mice with recurrent spontaneous abortion based on JAK1/STAT3 pathway[J]. Chin J Inf Tradit Chin Med, 2023, 30(6):87-93. DOI: 10.19879/j.cnki.1005-5304.202207237 . | |
39 | 赵欣, 刘淑君, 吴聪哲, 等. 补肾活血法与葛根黑苏汤对薄型子宫内膜不孕症治疗作用的影响[J]. 辽宁中医杂志, 2024, 10(2):126-130. |
ZHAO X, LIU S J, WU C Z, et al. Effect of kidney-invigorating and blood-activating method and Gegen heisu decoction on TCM syndrome score and inflammation in patients with thin endometrial infertility[J]. Liaoning J Tradit Chin Med, 2024, 10(2):126-130. | |
40 | 孟丹, 许琳, 赵红. 补肾调冲方治疗薄型子宫内膜不孕症患者的临床观察[J]. 世界中西医结合杂志, 2023, 18(8):1616-1619. DOI: 10.13935/j.cnki.sjzx.230820 . |
MENG D, XU L, ZHAO H. Clinical efficacy of Bushen Tiaochong prescription for improving thin endometrium-induced infertility[J]. World J Integr Tradit West Med, 2023, 18(8):1616-1619. DOI: 10.13935/j.cnki.sjzx.230820 . | |
41 | 朱娇芳, 阚惠, 王素改, 等. 补肾增膜方对薄型子宫不孕症患者子宫内膜血液流变学、容受性、性激素水平及自然妊娠结局影响[J]. 辽宁中医药大学学报, 2021, 23(11):188-192. DOI: 10.13194/j.issn.1673-842x.2021.11.040 . |
ZHU J F, KAN H, WANG S G, et al. Effect of Bushen zengmo decoction on endometrial hemorheology, receptivity, sex hormone level and natural pregnancy outcome in patients with thin uterine infertility[J]. J Liaoning Univ Tradit Chin Med, 2021, 23(11):188-192. DOI: 10.13194/j.issn.1673-842x.2021.11.040 . | |
42 | 杨斌, 孙洮玉, 周文清, 等. 补肾助孕方对肾虚薄型子宫内膜大鼠组织形态ERa、PR表达影响及容受性的调控作用[J]. 世界中西医结合杂志, 2021, 16(1):73-77. DOI: 10.13935/j.cnki.sjzx.210116 . |
YANG B, SUN T Y, ZHOU W Q, et al. Effect of Bushen Zhuyun recipe on ERa and PR expression and receptivity of rats with kidney deficiency and thin endometrium[J]. World J Integr Tradit West Med, 2021, 16(1):73-77. DOI: 10.13935/j.cnki.sjzx.210116 . | |
43 | 杨斌, 周文清, 陈莎, 等. 补肾助孕方对肾虚薄型子宫内膜大鼠内膜容受性的影响及机制研究[J]. 世界中医药, 2020, 15(17):2565-2569. DOI: 10.3969/j.issn.1673-7202.2020.17.009 . |
YANG B, ZHOU W Q, CHEN S, et al. Effects and mechanism study on Bushen Zhuyun formula on endometrial receptivity of rats with kidney deficiency and thinner endometrial[J]. World Chin Med, 2020, 15(17):2565-2569. DOI: 10.3969/j.issn.1673-7202.2020.17.009 . |
[1] | Yiqing ZHENG, Yasheng DENG, Yanping FAN, Tianwei LIANG, Hui HUANG, Yonghui LIU, Zhaobing NI, Jiang LIN. Application Analysis of Animal Models for Pelvic Inflammatory Disease Based on Data Mining [J]. Laboratory Animal and Comparative Medicine, 2024, 44(4): 405-418. |
[2] | WU Yue, LI Lu, ZHANG Yang, WANG Jue, FENG Tingting, LI Yitong, WANG Kai, KONG Qi. Integrative Analysis of Omics Data in Animal Models of Coronavirus Infection [J]. Laboratory Animal and Comparative Medicine, 2024, 44(4): 357-373. |
[3] | Guangyuan YAO, Ping DONG, Hao WU, Mei BAI, Ying DANG, Yue WANG, Kai HU. Research Progress on Animal Models of Long Bone Fractures [J]. Laboratory Animal and Comparative Medicine, 2024, 44(3): 289-296. |
[4] | Fangqi BAO, Haiye TU, Mingsun FANG, Qian ZHANG, Minli CHEN. Advances in Research on Pathological and Molecular Mechanism of Hyperuricemic Nephropathy Based on Animal Models [J]. Laboratory Animal and Comparative Medicine, 2024, 44(2): 180-191. |
[5] | Li ZHANG, Yu KUANG, Lingxia HAN. Advances in Comparative Medical Research on Anatomy and Histological Structure of Intervertebral Discs in Humans and Other Animals [J]. Laboratory Animal and Comparative Medicine, 2024, 44(2): 192-201. |
[6] | Tianwei LIANG, Yasheng DENG, Hui HUANG, Na RONG, Xin LIU, Yujie WANG, Jiang LIN. Preparation Methods and Evaluation Criteria Analysis of Animal Models for Perimenopausal Syndrome [J]. Laboratory Animal and Comparative Medicine, 2024, 44(1): 74-84. |
[7] | . Guidelines for the Selection of Animal Models and Preclinical Drug Trials for Spontaneous Intracerebral Hemorrhage (2024 Edition) [J]. Laboratory Animal and Comparative Medicine, 2024, 44(1): 3-30. |
[8] | Xin LIU, Shaobo SHI, Cui ZHANG, Bo YANG, Chuan QU. Construction and Evaluation of End-to-side Anastomosis Model of Autologous Arteriovenous Fistula in Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 595-603. |
[9] | Shuwu XIE, Ruling SHEN, Jinxing LIN, Chun FAN. Progress in Establishment and Application of Laboratory Animal Models Related to Development of Male Infertility Drugs [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 504-511. |
[10] | Yanjuan CHEN, Ruling SHEN. Progress in the Application of Animal Disease Models in the Medical Research on Colorectal Cancer [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 512-523. |
[11] | Rui ZHANG, Meiyu LÜ, Jianjun ZHANG, Jinlian LIU, Yan CHEN, Zhiqiang HUANG, Yao LIU, Lanhua ZHOU. Research Progress on Establishing and Evaluation of Acne Animal Models [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 398-405. |
[12] | Jin LU, Jian WANG, Lian ZHU, Guofeng YAN, Zhengwen MA, Yao LI, Jianjun DAI, Yinqiu ZHU, Jing ZHOU. Establishment of Preeclampsia Model in Goat and Evaluation on Maternal Biological Characteristics [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 371-380. |
[13] | Jiahui YU, Qian GONG, Lenan ZHUANG. Animal Models of Pulmonary Arterial Hypertension and Their Application in Drug Research [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 381-397. |
[14] | Yasheng DENG, Jiang LIN, Chiling GAN, Guanfeng ZENG, Jiayin HUANG, Huifang DENG, Yingxian MA, Siyin HAN. Literature Analysis of the Preparation Elements of Animal Models of Skin Photoaging and the Data of Subjects [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 406-414. |
[15] | Xue WANG, Yonghe HU. Analysis of Common Types and Construction Elements of Diabetic Mouse Models [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 415-421. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||